| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5946053 | Atherosclerosis | 2014 | 39 Pages |
Abstract
These findings identify niacin as a potent inhibitor of leukocyte MPO release and MPO-mediated formation of dysfunctional HDL. Niacin and niacin-related chemical entities may form important therapeutic agents for MPO-mediated inflammatory diseases.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Shobha H. Ganji, Vaijinath S. Kamanna, Moti L. Kashyap,